Skip to main content

Sigma-Aldrich, Proteome Sciences Lock in Distribution Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Proteome Sciences said today that it has struck a non-exclusive license agreement with Sigma-Aldrich enabling Sigma to continue selling the ProteoPrep kits in Europe, Japan, and Australia.

The agreement gives Proteome a signing fee and royalties on all eleven of its ProteoPrep kits sold in the three regions. It also covers all future products sold under the ProteoPrep trademark that contain chemicals and reagents for the disruption of cells, tissues, or other biological material and the extraction of biological molecules like proteins, lipids, and carbohydrates.

The trademark also covers methods and processes relating to assays for diagnosing diseases and chemical markers that disrupt cells, tissues, or other materials for determining drug targets and proteins and peptides, the company said.

Further financial terms of the agreement were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.